Chinese Journal of Cancer Research

Papers
(The TQCC of Chinese Journal of Cancer Research is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Pathogenic germline variants in mismatch repair genes in patients with microsatellite instability-high gastric cancer103
Efficacy of ctDNA methylation combined with traditional detection modality to detect liver cancer among high-risk patients: A multicenter diagnostic trial74
Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas70
Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial45
Transforming cancer cells for long-term living with cancer: An inspiring new approach36
Gastric cancer surgery in South Korea: Past, present, and future35
Focal ablation therapy presents promising results for selectively localized prostate cancer patients35
Plasma cell-free DNA methylation markers for detection and prognosis of gastric cancer: A case-control study32
Gut microbiota and acute graft-versus-host disease30
Clinical and molecular significance of homologous recombination deficiency positive non-small cell lung cancer in Chinese population: An integrated genomic and transcriptional analysis26
Detection and classification of breast lesions using multiple information on contrast-enhanced mammography by a multiprocess deep-learning system: A multicenter study20
Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumors20
Updates of CSCO guidelines for colorectal cancer version 202520
Current trends and future directions of artificial intelligence in lung cancer diagnosis19
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives17
Mn-based cGAS-STING activation for tumor therapy17
Development and validation of a multiparametric magnetic resonance imaging-based nomogram for predicting feasibility of sphincter-preserving surgery in mid-low rectal cancer16
Multi-omics profile of exceptional long-term survivors of AJCC stage III triple-negative breast cancer16
Prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery: Final results of a phase II trial16
Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A16
Impact of resection margin status on survival in gastric cancer: A retrospective cohort study16
Comparison of short- and long-term outcomes of robotic vs. laparoscopic gastrectomy for clinical serosa-invasive gastric cancer: A multicenter cohort study15
New roles of tumor-derived exosomes in tumor microenvironment15
Optimal response population after neoadjuvant therapy for patients with locally advanced gastric cancer: A multicenter study14
A multicenter study of a predictive model for pathological complete response after neoadjuvant therapy in breast cancer using multimodal digital biomarkers13
Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study13
Health economic evaluation on population-based Helicobacter pylori eradication and endoscopic screening for gastric cancer prevention13
Hypoxic tumor microenvironment: Destroyer of natural killer cell function13
Genomic characterization of peritoneal lavage cytology-positive gastric cancer12
Estimation of economic burden throughout course of cervical squamous intraepithelial lesion and cervical cancer in China: A nationwide multicenter cross-sectional study12
Postoperative chemoradiotherapy with capecitabine and oxaliplatin vs. capecitabine for pathological stage N2 rectal cancer12
Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors12
Lung cancer burden and trends from 2000 to 2018 in China: Comparison between China and the United State11
Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS) mutant tumors11
Research progress of minimally invasive surgery for gastric cancer11
Long-term adherence to gastric cancer screening in South Korea: A 10-year follow-up study11
Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression10
SOX11 as a potential prognostic biomarker in hepatocellular carcinoma linked to immune infiltration and ferroptosis10
Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignancies10
Development and validation of machine learning-based survival analysis to predict outcome in gastric cancer with adjuvant chemotherapy: A multicenter, longitudinal, cohort study10
Advances, breakthroughs, and challenges in gastric cancer surgery10
Adjuvant therapy for hormone receptor-positive breast cancer: Perspective from a survey on breast cancer physicians’ acceptance of practice-changing data10
Update of latest data for combined therapy for esophageal cancer using radiotherapy and immunotherapy: A focus on efficacy, safety, and biomarkers9
High-risk extranodal natural killer/T-cell lymphoma patients could benefit more from allogeneic hematopoietic stem cell transplantation as consolidation: A real-world multicenter analysis in China9
Molecular insights into immune evasion and therapeutic paradigms in pancreatic cancer9
Chromatin regulators TOP2A and PPARGC1A stratify prostate cancer risk and reveal TOP2A-driven progression via PI3K/AKT pathway8
Epidemiology, early detection, and management of breast cancer in China: A comprehensive review8
Efficacy and safety of dacomitinib as first-line treatment for advanced non-small cell lung cancer patients with epidermal growth factor receptor 21L858R mutation: A multicenter, case-series study in 8
Discovery and validation of indole nitroolefins as novel covalent GPX4 inhibitors for inducing ferroptosis in urological cancers8
Homoharringtonine combined with venetoclax and azacitidine: An effective and safe regimen for patients with refractory/relapsed acute myeloid leukemia8
Distal margin distance in radical resection of locally advanced rectal cancer after neoadjuvant therapy8
Integrating AI-driven single-cell analysis to decode epithelial heterogeneity: A prognostic signature and translational immunotherapy strategy targeting KRT18-induced PD-L1 in lung adenocarcinoma8
Clinicopathological and molecular features of HR+/HER2− breast cancer patients with distinct endocrine resistance patterns8
Allogeneic hematopoietic cell transplantation in vulnerable populations: Advances and perspectives8
0.16988897323608